Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 591 JPY -6.49% Market Closed
Market Cap: 234.8B JPY
Have any thoughts about
Sumitomo Pharma Co Ltd?
Write Note

Sumitomo Pharma Co Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sumitomo Pharma Co Ltd
Note Receivable Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Sumitomo Pharma Co Ltd
TSE:4506
Note Receivable
ÂĄ7.3B
CAGR 3-Years
3%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chugai Pharmaceutical Co Ltd
TSE:4519
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Note Receivable
ÂĄ22B
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A

See Also

What is Sumitomo Pharma Co Ltd's Note Receivable?
Note Receivable
7.3B JPY

Based on the financial report for Jun 30, 2024, Sumitomo Pharma Co Ltd's Note Receivable amounts to 7.3B JPY.

What is Sumitomo Pharma Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
24%

Over the last year, the Note Receivable growth was 11%. The average annual Note Receivable growth rates for Sumitomo Pharma Co Ltd have been 3% over the past three years , 24% over the past five years .

Back to Top